Journal of thrombosis and haemostasis : JTH
-
J. Thromb. Haemost. · Apr 2014
Randomized Controlled Trial Multicenter StudyTreatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.
Acute pulmonary embolism (PE) can worsen quality of life due to persistent dyspnea or exercise intolerance. ⋯ Treatment of patients with submassive pulmonary embolism with tenecteplase was associated with increased probability of a favorable composite outcome.